Об эффективности и безопасности препарата цернилтонр при хроническом абактериальном простатите и ДГПЖ

Автор: Сивков А.В., Бедретдинова Д.А.

Журнал: Экспериментальная и клиническая урология @ecuro

Статья в выпуске: 3, 2010 года.

Бесплатный доступ

Хронический абактериальный простатит, доброкачественная гиперплазия предстательной железы, лечение медикаментозное, цернилтон

Короткий адрес: https://sciup.org/142188230

IDR: 142188230

Список литературы Об эффективности и безопасности препарата цернилтонр при хроническом абактериальном простатите и ДГПЖ

Asakawa K., Nandachi N., Satoh S. et al. [Effects of cernitin pollen-extract (Cernilton) on inflammatory cyto-kines in sex-hormone-induced nonbacterial prostatitis rats]//Hinyokika Kiyo. 2001. Vol. 47. P. 459-465.
Leander G. [Preliminary research on the therapeutic effect of Cernilton on chronic prostatovesiculitis.]//Sven Lakartidn. 1962. Vol. 59. P. 3296-3304.
Aoki A., Naito K., Hashimoto O. et al. [Clinical evaluation of the effect of tamsulosin hydrochloride and cernitin pollen extract on urinary disturbance associated with benign prostatic hyperplasia in a multicentered study]//Hinyokika Kiyo. 2002. Vol. 48. P. 259-267.
Aslamazov E.G., Akhvlediani N.D., Vinarov A.Z., Aliaev Iu G. [Cernilton in the treatment of prostatic adenoma and chronic prostatitis]//Urologiia. 2007. Vol. P. 52, 54-56.
Dedhia R.C., McVary K.T. Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia//J Urol. -2008. Vol. 179. P. 2119-2125.
Kato T., Watanabe H., Takahashi H. et al. [Clinical experience on treatment of chronic prostatitis with cernilton tablet]//Hinyokika Kiyo. 1970. Vol. 16. P. 192-195.
Shaplygin L.V., Sivakov A.A. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis]//Urologiia. 2007. Vol. P. 35-37, 39.
Talpur N., Echard B., Bagchi D. et al. Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats//Mol Cell Biochem. 2003. Vol. 250. P. 21-26.
Wilt T., Mac Donald R., Ishani A. et al. Cernilton for benign prostatic hyperplasia//Cochrane Database Syst Rev. 2000. Vol. P. CD001042.
Xu J., Qian W. Q., Song J. D. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia]//Zhonghua Nan Ke Xue. 2008. Vol. 14. P. 533-537.
MacDonald R., Ishani A., Rutks I., Wilt T. J. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia//BJU Int. 2000. Vol. 85. P. 836-841.
Capodice J.L., Bemis D.L., Buttyan R. et al. Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome//Evid Based Complement Alternat Med. 2005. Vol. 2. P. 495-501.
Krysiak R., Okopien B., Szkrobka W., Herman Z. S. [Modern pharmacotherapy of benign prostatic hyperpla-sia]//Pol Merkur Lekarski. 2005. Vol. 19. P. 710-715.
Murphy A.B., Macejko A., Taylor A., Nadler R.B. Chronic prostatitis: management strategies//Drugs. 2009. Vol. 69. P. 71-84.
Nickel J.C. Treatment of chronic prostatitis/chronic pelvic pain syndrome//Int J Antimicrob Agents. 2008. Vol. 31 Suppl 1. P. S112-116.
Potts J.M. Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome//Curr Urol Rep. 2005. Vol. 6. P. 313-317.
Kamijo T., Sato S., Kitamura T. Effect of cernitin pollen-extract on experimental nonbacterial prostatitis in rats//Prostate. 2001. Vol. 49. P. 122-131.
Preuss H.G., Marcusen C., Regan J. et al. Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH)//Int Urol Nephrol. 2001. Vol. 33. P. 217-225.
Krieger J.N., Ross S.O., Riley D.E. Chronic prostatitis: epidemiology and role of infection//Urology. 2002. Vol. 60. P. 8-12; discussion 13.
McNaughton Collins M., Barry M.J. Epidemiology of chronic prostatitis//Curr Opin Urol. 1998. Vol. 8. P. 33-37.
Pontari M.A. Chronic prostatitis/chronic pelvic pain syndrome//Urol Clin North Am. 2008. Vol. 35. P. 81-89.
Krieger J.N. Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia//Minerva Urol Nefrol. 2004. Vol. 56. P. 99-107.
Лопаткин Н.А. Руководство по урологии. Москва: 1998.
Jonsson K., Hedelin H. Chronic abacterial prostatitis: Living with a troublesome disease affecting many aspects of life//Scand J Urol Nephrol. 2008. Vol. P. 1-6.
Chiang P.H., Chiang C.P. Therapeutic effect of transurethral needle ablation in non-bacterial prostatitis: chronic pelvic pain syndrome type IIIa//Int J Urol. 2004. Vol. 11. P. 97-102.
Lu M., Zhao S.T., Wang S.M. et al. [Alpha-blockers and bioflavonoids in men with chronic nonbacterial prostatitis (NIH-IIIa): a prospective, placebocontrolled trial]//Zhonghua Liu Xing Bing Xue Za Zhi. 2004. Vol. 25. P. 169-172.
Nickel J.C., Downey J., Pontari M.A. et al. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)//BJU Int. 2004. Vol. 93. P. 991-995.
Nickel J.C., Johnston B., Downey J. et al. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial//Urology. 2000. Vol. 56. P. 413-417.
Schaeffer A.J. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)//J Urol. 2005. Vol. 173. P. 845.
Wang W., Hu W.L., Yang H. et al. [Effects of antibiotic and anti-inflammatory treatment on serum PSA and free PSA levels in patients with chronic prostatitis IIIA]//Zhonghua Nan Ke Xue. 2006. Vol. 12. P. 787-790.
Zeng X., Ye Z., Yang W. et al. [Clinical evaluation of celecoxib in treating type IIIA chronic prostatitis]//Zhonghua Nan Ke Xue. 2004. Vol. 10. P. 278-281.
Shoskes D.A. Phytotherapy in chronic prostatitis//Urology. 2002. Vol. 60. P. 35-37; discussion 37.
Monden K., Tsugawa M., Ninomiya Y. et al. [A Japanese version of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI, Okayama version) and the clinical evaluation of cernitin pollen extract for chronic nonbacterial prostatitis]//Nippon Hinyokika Gakkai Zasshi. 2002. Vol. 93. P. 539-547.
Wagenlehner F.M., Schneider H., Ludwig M. et al. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebocontrolled phase 3 study//Eur Urol. 2009. Vol. 56. P. 544-551.
Coyne K.S., Sexton C.C., Thompson C.L. et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study//BJU Int. 2009. Vol. 104. P. 352-360.
Pel J.J., Bosch J.L., Blom J.H. et al. Development of a non-invasive strategy to classify bladder outlet ob-struction in male patients with LUTS//Neurourol Urodyn. 2002. Vol. 21. P. 117-125.
Bruskewitz R. Management of symptomatic BPH in the US: who is treated and how?//Eur Urol. 1999. Vol. 36 Suppl 3. P. 7-13.
Li N.C., Wu S.L., Jin J. et al. [Comparison of different drugs on the treatment of benign prostate hyperpla-sia]//Zhonghua Wai Ke Za Zhi. 2007. Vol. 45. P. 947-950.

Еще

Статья